NRG1 and metastatic melanoma: In fact, our new findings could have potential diagnostic implications in the field of liquid biopsy, as the activation of the ErbB3-NRG1 axis could be implicated as a new early biomarker able to predict the response to the targeted therapies in metastatic melanoma patients.